ABOUT US

OUR STORY

In 2013, the Biomaterials and Bioengineering Laboratory of the French National Institute for Health and Medical Research (Inserm UMR 1121), co-directed by our CSO, Dr. Philippe LAVALLE, discovered the antimicrobial properties of the anti-inflammatory coatings we were working on.

Between 2016 and 2018, we worked to develop our technology with the support of SATT Conectus .

In 2019, our CEO, Dr. Nihal Engin VRANA, together with 2 collaborators, Dr. Philippe LAVALLE and Dr. Angela MUTSCHLER created SPARTHA Medical and were then incubated at SEMIA.

TEAM UP

To date, the team has expanded with a production manager, Ms. Cynthia CALLIGARO; a Business Developer, Dr. Pulchérie MATSODOUM and a CFO, M. Thierry MIGNOT.

We are also privileged to have a multidisciplinary and experienced scientific advisory board.